Parker J, Sawtell R, Gagnon L, et al. PBI-4050 Is Safe and Well Tolerated and Shows Evidence of Benefit in Idiopathic Pulmonary Fibrosis. ATS 2017, A7606.
25ste Nationale Longkanker Symposium
feb 2024 | Chirurgie, Immuuntherapie, Longoncologie, Radiotherapie